Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue

American Journal of Physiology - Cell Physiology

Volumn 288, Issue 6 57-6, 2005, Pages

  Danieli Betto, Daniela ^a   Germinario, Elena ^a   Esposito, Alessandra ^a   Megighian, Aram ^a   Midrio, Menotti ^a   Ravara, Barbara ^a   Damiani, Ernesto ^a   Dalla Libera, Luciano ^b   Sabbadini, Roger A ^c   Betto, Romeo ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Action potential; Sphingosine; Sphingosine kinase

Indexed keywords

CALCIUM ION; N,N DIMETHYLSPHINGOSINE; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; BISINDOLYLMALEIMIDE; CALCIUM; DRUG DERIVATIVE; INDOLE DERIVATIVE; LYSOPHOSPHOLIPID; MALEIMIDE DERIVATIVE; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ACTION POTENTIAL; AMPLITUDE MODULATION; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTENSOR DIGITORUM LONGUS MUSCLE; FATIGUE; HYPOTHESIS; MOUSE; MUSCLE CONTRACTILITY; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; MOUSE STRAIN; MUSCLE CONTRACTION; MUSCLE FATIGUE; PHYSIOLOGY;

ANIMALS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; LYSOPHOSPHOLIPIDS; MALEIMIDES; MICE; MICE, INBRED STRAINS; MUSCLE CONTRACTION; MUSCLE FATIGUE; MUSCLE, SKELETAL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SPHINGOSINE;

EID: 22244446439     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00246.2004     Document Type: Article

References (51)

1. Allen DG, Lannergren J, and Westerblad H. Muscle cell function during prolonged activity: cellular mechanisms of fatigue. Exp Physiol 80: 497-527, 1995.
2. Andrieu-Abadie N and Levade T. Sphingomyelin hydrolysis during apoptosis. Biochim Biophys Acta 1585: 126-134, 2002.
3. Baker AJ, Longuemare MC, Brandes R, and Weiner MW. Intracellular tetanic calcium signals are reduced in fatigue of whole skeletal muscle. Am J Physiol Cell Physiol 264: C577-C582, 1993.
4. Bencini C, Squecco R, Piperio C, Formigli L, Meacci E, Nosi D, Tiribilli B, Vassalli M, Quercioli F, Bruni P, Zecchi Orlandini S, and Francini F. Effects of sphingosine 1-phosphate on excitation-contraction coupling in mammalian skeletal muscle. J Muscle Res Cell Motil 24: 539-554, 2003.
5. Betto R, Teresi A, Fachechi-Cassano G, Salviati G, and Sabbadini RA. Sphingosine inhibits calcium release from sarcoplasmic reticulum membranes. Adv Exp Med Biol 311: 403-404, 1992.
6. Betto R, Teresi A, Duca M, Turcato F, Danieli-Betto D, and Sabbadini RA. Inability of sphingosine and calmodulin to control ryanodine receptor in malignant hyperthermia. Basic Appl Myol 12: 159-167, 2002.
7. Cavalli AL, Ligutti JA, Gellings NM, Castro E, Page MT, Klepper RE, Palade PT, McNutt WT, and Sabbadini RA. The role of TNFα and sphingolipid signaling in cardiac hypoxia: Evidence that cardiomyoytes release TNFα and sphingosine. Basic Appl Myol 12: 167-176, 2002.
8. Chatterjee S. Neutral sphingomyelinase: past, present and future. Chem Phys Lipids 102: 79-96, 1999.
9. Dalla Libera L, Sabbadini R, Renken C, Ravara B, Sandri M, Betto R, Angelini A, and Vescovo G. Apoptosis in the skeletal muscle of rats with heart failure is associated with increased serum levels of TNF-α and sphingosine. J Mol Cell Cardiol 33: 1871-1878, 2001.
10. Dalla Libera L, Ravara B, Volterrani M, Gobbo V, Della Barbera M, Angelini A, Danieli-Betto D, Germinario E, and Vescovo G. Beneficial effects of GH/IGF-1 on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol 286: C138-C144, 2004.
11. Danieli-Betto D, Germinario E, Esposito A, Biral D, and Betto R. Effects of fatigue on sarcoplasmic reticulum and myofibrillar properties of rat single muscle fibers. J Appl Physiol 89: 891-898, 2000.
12. Dettbarn CA, Betto R, Salviati G, Palade P, Jenkins GM, and Sabbadini RA. Modulation of cardiac sarcoplasmic reticulum ryanodine receptor by sphingosine. J Mol Cell Cardiol 26: 229-242, 1994.
13. Deutschman DH, Carstens JS, Klepper RL, Smith WS, Page MT, Young TR, Gleason LA, Nakajima N, and Sabbadini RA. Predicting obstructive coronary artery disease with serum sphingosine-1-phosphate. Am Heart J 146: 62-68, 2003.
14. Dobrzyń A and Górski J. Effect of acute exercise on the content of free sphinganine and sphingosine in different skeletal muscle types of the rat. Horm Metab Res 34: 523-529, 2002.
15. Dobrzyń A, Żendzian-Piotrowska M, and Górski J. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. J Physiol Pharmacol 55: 305-313, 2004.
16. Edman KA and Lou F. Myofibrillar fatigue versus failure of activation during repetitive stimulation of frog muscle fibres. J Physiol 457: 655-673, 1992.
17. Fitts RH. Cellular mechanisms of muscle fatigue. Physiol Rev 74: 49-94, 1994.
18. 12 myoblastic cells. Am J Physiol Cell Physiol 282: C1361-C1373, 2002.
19. Ghosh N, Sabbadini R, and Chatterjee S. Identification, partial purification, and localization of a neutral sphingomyelinase in rabbit skeletal muscle: neutral sphingomyelinase in skeletal muscle. Mol Cell Biochem 189: 161-168, 1998.
20. Hannun YA and Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243: 500-507, 1989.
21. Hannun YA and Obeid LM. The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind, J Biol Chem 277: 25847-25850, 2002.
22. + currents via a Ras- and Raf-1-dependent pathway in cultured oligodendrocytes. J Neurosci 18: 8712-8719, 1998.
23. 2+ current by lysosphingolipids in RINm5F insulinoma cells. Mol Pharmacol 53: 862-869, 1998.
24. Itagaki K and Hauser CJ. Sphingosine 1-phosphate, a diffusible calcium influx factor mediating store-operated calcium entry. J Biol Chem 278: 27540-27547, 2003.
25. Kluk MJ and Hla T. Signaling of sphingosine-1-phosphate via the S1P/EDG-family of G-protein-coupled receptors. Biochim Biophys Acta 1582: 72-80, 2002.
26. Kolesnick R and Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328, 1994.
27. Maceyka M, Payne SG, Milstien S, and Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585: 193-201, 2002.
28. Margreth A, Damiani E, and Tobaldin G. Ratio of dihydropyridine to ryanodine receptors in mammalian and frog twitch muscles in relation to the mechanical hypothesis of excitation-contraction coupling. Biochem Biophys Res Commun 197: 1303-1311, 1993.
29. 2+ channel conductance. Circ Res 75: 981-989, 1994.
30. 12 myoblasts. Biochem J 381: 655-663, 2004.
31. 2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol 56: 485-508, 1994.
32. Midrio M, Danieli-Betto D, Megighian A, and Betto R. Early effects of denervation on sarcoplasmic reticulum properties of slow-twitch rat muscle fibres. Pflügers Arch 434: 398-405, 1997.
33. Nava VE, Lacana E, Poulton S, Liu H, Sugiura M, Kono K, Milstien S, Kohama T, and Spiegel S. Functional characterization of human sphingosine kinase-1. FEBS Lett 473: 81-84, 2000.
34. 2+-release channel activity by sphingosine. Am J Physiol Cell Physiol 272: C1465-C1474, 1997.
35. Olivera A and Spiegel S. Sphingosine kinase: a mediator of vital cellular functions. Prostagtandins 64: 123-134, 2001.
36. Pedersen BK, Ostrowski K, Rohde T, and Bruunsgaard H. The cytokine response to strenuous exercise. Can J Physiol Pharmacol 76: 505-511, 1998.
37. Pyne S and Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349: 385-402, 2000.
38. Sabbadini RA, Betto R, Teresi A, Fachechi-Cassano G, and Salviati G. The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J Biol Chem 267: 15475-15484, 1992.
39. Sabbadini R, McNutt W, Jenkins G, Betto R, and Salviati G. Sphingosine is endogenous to cardiac and skeletal muscle. Biochem Biophys Res Commun 193: 752-758, 1993.
40. Sabbadini RA, Danieli-Betto D, and Betto R. The role of sphingolipids in the control of skeletal muscle function: a review. Ital J Neurol Sci 20: 423-430, 1999.
41. Salvatori S, Furlan S, Millikin B, Sabbadini R, Betto R, Margreth A, and Salviati G. Localization of protein kinase C in skeletal muscle T-tubule membranes. Biochem Biophys Res Commun 196: 1073-1080, 1993.
42. 2+ release channel (ryanodine receptor) activity by sphingolipid bases: mechanism of action. Chem Phys Lipids 104: 1-11, 2000.
43. Spiegel S and Milstien S. Sphingosine 1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407, 2003.
44. Yasui K and Palade P. Sphingolipid actions on sodium and calcium currents of rat ventricular myocytes. Am J Physiol Cell Physiol 270: C645-C649, 1996.
45. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, and Kume S. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem (Tokyo) 121: 969-973, 1997.
46. Yatomi Y, Ruan F, Megidish T, Toyokuni T, Hakomori S, and Igarashi Y. N,N-Dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets. Biochemistry 35: 626-633, 1996.
47. Yatomi Y, Welch RJ, and Igarashi Y. Distribution of sphingosine 1-phosphate, a bioactive sphingolipid, in rat tissues. FEBS Lett 404: 173-174, 1997.
48. 2+/calmodulin-dependent translocation of sphingosine kinase: role in plasma membrane relocation but not activation. Cell Calcium 33: 119-128, 2003.
49. - current by LPA and S1P in cultured corneal keratocytes. Invest Ophthalmol Vis Sci 43: 3202-3208, 2002.
50. i and force-in skeletal muscle. Acta Physiol Scand 156: 407-416, 1996.
51. Westerblad H, Lee JA, Lannergren J, and Allen DG. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol Cell Physiol 261: C195-C209, 1991.